Ayako Yukita
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- Toxicology top 10%
-
- Angiogenesis and VEGF in Cancer 7
- Biochemical and Molecular Research 2
-
- Vascular Tumors and Angiosarcomas 2
- Cancer Cells and Metastasis 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- HIV/AIDS drug development and treatment 2
-
- Chemical and Physical Properties in Aqueous Solutions 1
- Co-authors
- Makoto AsanoShinichi KondoT MatsumotoHitoshi SuzukiHideo SuzukiGeorge R. PettitToshiaki SegawaYoshiaki Kamano
- Journals
- Journal of Medicinal Chemistry (1 paper)International Journal of Cancer (1 paper)Bioorganic & Medicinal Chemistry (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Ayako Yukita
12 papers receiving 702 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 224
- Toxicology 33
- Molecular Biology 543
- Oncology 211
- Biomaterials 71
Countries citing papers authored by Ayako Yukita
This map shows the geographic impact of Ayako Yukita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Yukita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Yukita more than expected).
Fields of papers citing papers by Ayako Yukita
This network shows the impact of papers produced by Ayako Yukita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Yukita. The network helps show where Ayako Yukita may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ayako Yukita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 89 | |
| 2 | 2000 | 10 | |
| 3 | Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo. | 2000 | 39 |
| 4 | 1999 | 49 | |
| 5 | 1999 | 29 | |
| 6 | 1999 | 4 | |
| 7 | 1998 | 81 | |
| 8 | 1998 | 112 | |
| 9 | 1998 | 39 | |
| 10 | 1998 | 38 | |
| 11 | 1995 | 18 | |
| 12 | Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. | 1995 | 216 |
About Ayako Yukita
Ayako Yukita is a scholar working on Filtration and Separation, Cancer Research and Biochemistry, having authored 12 papers that have together received 724 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Biochemical and Molecular Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HIV/AIDS drug development and treatment (2 papers), Cancer Cells and Metastasis (2 papers) and Chemical and Physical Properties in Aqueous Solutions (1 paper). The work is most often cited by research in Cancer Research (224 citations), Toxicology (33 citations) and Molecular Biology (543 citations). Ayako Yukita has collaborated with scholars based in Japan and United States. Frequent co-authors include Makoto Asano, Shinichi Kondo, T Matsumoto, Hitoshi Suzuki, Hideo Suzuki, George R. Pettit, Toshiaki Segawa, Yoshiaki Kamano, Tatsuo Tanaka and Keigo Matsumoto. Their work appears in journals such as Journal of Medicinal Chemistry, International Journal of Cancer and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.